Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | QTTB:NMQ since announced | Transaction value |
---|---|---|
Q32 Bio Inc | 9.41% | -- |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Codexis Inc | 74.23m | -65.13m | 203.91m | 174.00 | -- | 2.57 | -- | 2.75 | -0.9412 | -0.9412 | 1.07 | 1.12 | 0.4039 | 5.92 | 4.34 | 426,632.20 | -35.43 | -17.13 | -43.38 | -20.23 | 82.29 | 77.29 | -87.73 | -37.04 | 3.63 | -- | 0.2617 | -- | -49.39 | 2.97 | -126.96 | -- | 9.80 | -- |
Prelude Therapeutics Inc | 0.00 | -125.55m | 204.89m | 128.00 | -- | 0.7447 | -- | -- | -1.88 | -1.88 | 0.00 | 5.01 | 0.00 | -- | -- | 0.00 | -56.37 | -47.21 | -61.52 | -51.07 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.54 | -- | 46.03 | -- |
Actinium Pharmaceuticals Inc | 81.00k | -46.45m | 207.29m | 49.00 | -- | 4.67 | -- | 2,559.17 | -1.72 | -1.72 | 0.003 | 1.49 | 0.0009 | -- | -- | 1,653.06 | -48.80 | -46.98 | -53.25 | -52.71 | -- | -- | -57,346.91 | -6,683.95 | -- | -- | 0.0006 | -- | -92.14 | -- | -47.86 | -- | 9.75 | -- |
Skye Bioscience Inc | 0.00 | -37.50m | 212.19m | 11.00 | -- | 2.69 | -- | -- | -4.50 | -4.50 | 0.00 | 2.81 | 0.00 | -- | -- | 0.00 | -75.43 | -232.67 | -101.00 | -- | -- | -- | -- | -- | -- | -46.11 | 0.0552 | -- | -- | -- | -93.23 | -- | 23.38 | -- |
Fractyl Health Inc | 148.00k | -83.16m | 212.66m | 102.00 | -- | 2.53 | -- | 1,436.91 | -1.73 | -1.73 | 0.0031 | 1.76 | -- | -- | -- | 1,450.98 | -- | -- | -- | -- | 37.16 | -- | -46,270.95 | -- | 9.37 | -5.10 | 0.2542 | -- | -- | -- | -48.15 | -- | -- | -- |
Q32 Bio Inc | 354.00k | -83.09m | 215.56m | 39.00 | -- | 4.42 | -- | 608.91 | -25.73 | -25.73 | 0.1182 | 4.09 | 0.002 | -- | -- | 50,571.43 | -34.17 | -34.98 | -40.05 | -37.92 | -- | -- | -16,901.98 | -971.76 | -- | -- | 0.2039 | -- | -63.97 | -26.32 | -2,156.96 | -- | -60.90 | -- |
Rezolute Inc | 0.00 | -58.21m | 216.32m | 51.00 | -- | 2.38 | -- | -- | -1.14 | -1.14 | 0.00 | 1.77 | 0.00 | -- | -- | 0.00 | -52.46 | -58.48 | -55.28 | -63.38 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.13 | -- | 92.29 | -- |
Gossamer Bio Inc | 0.00 | -172.58m | 217.12m | 135.00 | -- | 8.13 | -- | -- | -1.05 | -1.05 | 0.00 | 0.1181 | 0.00 | -- | -- | 0.00 | -72.02 | -57.43 | -85.67 | -64.38 | -- | -- | -- | -- | -- | -14.73 | 0.8854 | -- | -- | -- | 21.61 | -- | -- | -- |
Monte Rosa Therapeutics Inc | 1.06m | -135.28m | 218.41m | 133.00 | -- | 1.18 | -- | 205.27 | -2.53 | -2.53 | 0.0197 | 3.04 | 0.0037 | -- | 0.768 | 8,000.00 | -46.99 | -- | -52.64 | -- | -- | -- | -12,714.47 | -- | -- | -- | 0.00 | -- | -- | -- | -24.75 | -- | -- | -- |
Inovio Pharmaceuticals Inc | 717.07k | -124.94m | 218.43m | 122.00 | -- | 2.09 | -- | 304.61 | -5.54 | -5.54 | 0.0317 | 4.04 | 0.0036 | -- | 0.5465 | 5,877.62 | -63.15 | -59.52 | -78.79 | -71.29 | -- | -- | -17,423.39 | -4,097.36 | -- | -- | 0.00 | -- | -91.89 | -51.33 | 51.71 | -- | -31.22 | -- |
Zura Bio Ltd | 0.00 | -60.18m | 218.44m | 14.00 | -- | 2.45 | -- | -- | -1.63 | -1.63 | 0.00 | 1.40 | 0.00 | -- | -- | 0.00 | -86.77 | -- | -127.21 | -- | -- | -- | -- | -- | -- | -- | 0.021 | -- | -- | -- | -2,050.99 | -- | -- | -- |
ESSA Pharma Inc | 0.00 | -27.73m | 218.71m | 50.00 | -- | 1.64 | -- | -- | -0.6282 | -0.6282 | 0.00 | 3.01 | 0.00 | -- | -- | 0.00 | -18.71 | -23.01 | -19.12 | -23.67 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.27 | -- | -- | -- |
Omeros Corp | 0.00 | -179.09m | 223.09m | 198.00 | -- | -- | -- | -- | -2.90 | -1.97 | 0.00 | -1.23 | 0.00 | -- | -- | 0.00 | -35.90 | -55.51 | -44.81 | -70.10 | -- | -- | -- | -- | -- | -5.39 | 1.19 | -- | -- | -- | 3.91 | -- | -5.56 | -- |
Vicapsys Life Sciences Inc | 0.00 | -1.08m | 225.46m | 2.00 | -- | -- | -- | -- | -0.0327 | -0.0327 | 0.00 | -0.0416 | 0.00 | -- | -- | 0.00 | -364.66 | -- | -- | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- | -- | -317.25 | -- | -- | -- |
Mersana Therapeutics Inc | 38.30m | -134.81m | 227.59m | 123.00 | -- | 8.13 | -- | 5.94 | -1.14 | -1.14 | 0.3203 | 0.2287 | 0.1549 | -- | -- | 311,365.80 | -54.52 | -61.68 | -75.37 | -81.35 | -- | -- | -352.01 | -622.19 | -- | -- | 0.4749 | -- | 38.65 | 28.32 | 15.94 | -- | 9.61 | -- |
Data as of Jul 03 2024. Currency figures normalised to Q32 Bio Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Temasek Holdings Pte Ltd. (Investment Management)as of 31 Mar 2024 | 313.94k | 2.63% |
Adar1 Capital Management LLCas of 31 Mar 2024 | 187.57k | 1.57% |
Platinum Investment Management Ltd.as of 31 Mar 2024 | 109.96k | 0.92% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 106.75k | 0.89% |
Exome Asset Management LLCas of 31 Mar 2024 | 65.02k | 0.54% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 41.30k | 0.35% |
Affinity Asset Advisors LLCas of 31 Mar 2024 | 27.78k | 0.23% |
Ensign Peak Advisors, Inc.as of 31 Mar 2024 | 25.73k | 0.22% |
BML Capital Management LLCas of 31 Mar 2024 | 24.89k | 0.21% |
Ikarian Capital LLCas of 31 Mar 2024 | 22.34k | 0.19% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.